Distributions of ischemic heart disease risk factors in patients who were admitted for angioplasty in Iran


The aim of this study was to study the prevalence of different risk factors of coronary artery disease (CAD) in Patients who were admitted for angioplasty. Methods: A cross-sectional study was conducted on 333 patients who were admitted with diagnosis as a CAD and candidates for angioplasty in Imam Khomeini hospital, Ahvaz city, Iran 2011. The prevalence of different risk factors was determined using descriptive statistics. Results: The prevalence of CAD risk factors in overall subjects were: 1) 45.3% hypertension (considering >140/90 mmHg); 2) 34.5% high cholesterol (>240 mg/dl); 3) 27.6% diabetic mellitus (>126 mg/dL); 4) family history of heart disease: 20.7%; 5) smokers: 19.9%. Conclusion: This data have shown the prevalence of IHD (Ischemic Heart Disease) risk factors specially about hypertension in patients with IHD was high, so could require urgent decision making to national control program of non-communicable diseases in Iran.

Share and Cite:

Assareh, A. , Cheraghi, M. , Nourizadeh, M. , Daeenejad, F. , Haybar, H. and Kiarsi, M. (2013) Distributions of ischemic heart disease risk factors in patients who were admitted for angioplasty in Iran. World Journal of Cardiovascular Diseases, 3, 45-49. doi: 10.4236/wjcd.2013.34A007.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Gus, I. and Zielinsky, P. (1999) As cardiopatias no Brasil. In: Ferreira, C. and Póvoa, R., Eds., Cardiologiapara O ClínicoGeral, Atheneu, Rio de Janeiro, 131-143.
[2] Thom, T., Haase, N., Rosamond, W., Howard, V.J. and American Heart Association. (2006) Stroke statistics heart disease and update. Circulation, 113, e85-e151.
[3] Hatmi, Z.N., Tahvildari, S., GafarzadehMotlag, A. and SabouriKashani, A. (2007) Prevalence of coronary artery disease risk factors in Iran: Apopulation based survey. BMC Cardiovascular Disorders, 7, 32. doi:10.1186/1471-2261-7-32
[4] World Health Organization. (2002) The world health report 2002: Reducing risks, promoting healthy life. WHO, Geneva, 27 October 2002.
[5] Naghavi, M. and Jafari, N. (2007) Death profile in Iran, 2005. Iranian Ministry of Health, Tehran.
[6] Shimoda, M., Sugayama, S., Kim, C. and Ebaid, M. (1996) Orientacao Familiar preventiva: Aspectosgenéti cosdas doencascardiovasculares e perspectivasfuturas. Revista da Sociedade de Cardiologia do Estado de Sao Paulo, 6, 623-627.
[7] Ockene, I.S. and Miller, N.H. (1997) Cigarette smoking, cardiovascular disease, and stroke. A statement for healthcare professionals from the American Heart Association. Circulation, 96, 3243-3247. doi:10.1161/01.CIR.96.9.3243
[8] Jee, S.H., Suh, I., Kim, I.S. and Appel, L.J. (1999) Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: The Korea medical insurance corporation study. The Journal of the American Medical Association, 282, 2149-2155. doi:10.1001/jama.282.22.2149
[9] Steenland, K., Thun, M., Lally, C., et al. (1996) Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation, 94, 622-628. doi:10.1161/01.CIR.94.4.622
[10] Kawachi, I., Colditz, G.A., Speizer, F.E., et al. (1997) A prospective study of passive smoking and coronary heart disease. Circulation, 95, 2374-2379. doi:10.1161/01.CIR.95.10.2374
[11] Law, M.R., Morris, J.K. and Wlad, N.J. (1997) Environ mental tobacco exposure and ischaemic heart disease: An evaluation of the evidence. British Medical Journal, 315, 973-980. doi:10.1136/bmj.315.7114.973
[12] He, J., Vupputri, S., Allen, K., et al. (1999) Passive smoking and the risk of coronary heart diseasea meta-analisys of epidemiologic studies. The New England Journal of Medicine, 340, 920-926. doi:10.1056/NEJM199903253401204
[13] Fein, F. and Scheuer, J. (1990) Heart disease in diabetes mellitus: Theory and practice. In: Rifkin, H. and Port, D. Eds., Diabetes Mellitus, Elsever, New York, 812-823.
[14] Aram, V. Chobanian, M.D. and Bakris, G.L. (2003) The 7th Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA, 289, 2560-2571.
[15] Wilking, S.V.B., Belanger, A.J., Kannel, W.B., D’Agostinho, R.B. and Steel, K. (1988) Determinants of isolated systolic hypertension. The Journal of the American Medical Association, 260, 3451-3455. doi:10.1001/jama.1988.03410230069030
[16] Haghdoost, A.A. Sadeghirad, B. and Rezazadehkermani, M. (2008) Epidemiology and heterogeneity of hypertension in Iran: A systematic review. Archives of Iranian Medicine, 11, 444-452.
[17] Gazino, J.M. (2005) Global burden of cardio vascular disease. In: Braunwald, E., Ed., Heart disease: A textbook of cardiovascular medicine, USA 7th Edition, WB Saunders Company, Philadelphia, 7.
[18] Sarraf-Zadegan, N., Amboshtam, M. and Rafiei, M. (1999) Risk factors for coronary artery disease in Isfahan, Iran. European Journal of Public Health, 9, 20-26. doi:10.1093/eurpub/9.1.20
[19] Azizi, F., Rahmani, M., Emami, H., Mirmiran, P., Haji pour, R., Madjid, M., et al. (2002) Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). SOZ Preventive Medicine, 47, 408-426. doi:10.1007/s000380200008
[20] Baguet, J.P., Barone-Rochette, G. and Mallion, J.M. (2006) European society of hypertension scientific news letter: Hypertension and coronary heart disease. Journal of Hypertension, 24, 2323-2325. doi:10.1097/01.hjh.0000249719.05006.58
[21] Akbarzadeh, F., Pourafkari, L., HashemiJazi, S.M., Hesami, L. and Habibi, V. (2010) Prevalence and severity of coronary of artery disease among hypertensive and nor motensive patients. ARYA Atherosclerosis Journal, 5, 186-190.
[22] Gus, I., Fischmann, A. and Medina, C. (2002) Prevalence of risk factors for coronary artery disease in the brazilian state of riogrande do sul, Arquivos Brasileiros de Cardiologia, 78, 484-90. doi:10.1590/S0066-782X2002000500005
[23] Thelle, D.S., Shaper, A.G. and Whitehead, T.P. (1983) Blood lipids in middle-aged British men. British Heart Journal, 49, 5-13.
[24] Sharifi, F., Mousavinasab, S.N., Soruri, R., Saeini, M. and Dinmohammadi, M. (2008) High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population. Metabolic Syndrome and Related Disorders, 6, 187-95. doi:10.1089/met.2008.0007
[25] Ebrahimi, M., Kazemi-Bajestani, S.M., Ghayour-Mobar han, M., Moohebati, M., Paydar, R., Azimi-Nezhad, M., et al. (2009) Metabolic syndrome may not be a good predictor of coronary artery disease in the Iranian population: Population-specific definitions are required. The Scientific World Journal, 9, 86-96. doi:10.1100/tsw.2009.17
[26] Kazemi-Bajestani, S.M., Ghayour-Mobarhan, M., Ebrahimi, M., Moohebati, M., Esmaeili, H.A., Parizadeh, M.R., et al. (2007) Serum copper and zinc concentrations are lower in Iranian patients with angiographically de fined coronary artery disease than in subjects with a nor mal angiogram. Journal of Trace Elements in Medicine and Biology, 21, 22-28. doi:10.1016/j.jtemb.2006.11.005
[27] Ghayour-Mobarhan, M., Sahebkar, A., Parizadeh, S.M., Moohebati, M., Tavallaie, S., Rezakazemi-Bajestani, S.M., et al. (2008) Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International Journal of Experimental Pathology, 89, 209-215. doi:10.1111/j.1365-2613.2008.00586.x
[28] Parizadeh, S.M., Moohebati, M., Ghafoori, F., Ghayour Mobarhan, M., Kazemi-Bajestani, S.M., Tavallaie, S., et al. (2009) Serum selenium and glutathione peroxidase concentrations in Iranian patients with angiography-de fined coronary artery disease. Angiology, 60, 186-191.
[29] Janghorbani, M., Amini, M. and Tavassoli, A. (2006) Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors. Acta Cardiologica, 61, 13-20. doi:10.2143/AC.61.1.2005135
[30] Karimi, A., Marzban, M., Movahedi, N., Salehiomran, A., Sadeghian, S. and Goodarzynejad, H. (2009) Traditional cardiac risk factors profile in Iranian patients undergoing coronary artery bypass surgery. Acta Cardiologica, 64, 371-377.doi:10.2143/AC.64.3.2038024
[31] Mohammad, K., Zali, M., Masjedi, M. and Majdzadeh, S. (1998) Cigarette smoking in Iran based on a national health survey. Medical Journal of the Islamic Republic of Iran, 1, 33-37.
[32] Mohammad, K., Noorbala, A., Majdzadeh, S. and Karim loo, M. (2001) Trend of smoking prevalence in Iran from 1991 through 1999 based on two national health surveys. Hakim Research Journal, 4, 290-297.
[33] Amani, R., Nourizadeh, M., et al. (2010) Nutritional related cardiovascular risk factors in patients with coronary artery disease in Iran: A case-control study. Nutrition Journal, 9, 70.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.